Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Pfizer, Inc. | PFE | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0 | +0% | 36.36 | - | - | - | 36.36 | 02:05:03 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | - | - | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Pfizer, Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 212.69B | 5.85B | $ 21.31B | 3.57 | 10.10 | 5.95B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.36 | 3.74% | 05/10/2018 | -330.49k | 77.40% |
Pfizer, Inc. News
Pfizer Announces Extension of Zithromax® Antibiotic Donation Program through 2025 to Help Eliminate World’s Leading Infect... Business Wire • Tue Jun 12, 2018 7:00 AM (6 days ago)
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) • Fri Jun 08, 2018 1:57 PM (1 week ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Fri Jun 08, 2018 1:12 PM (1 week ago)
U.S. FDA & European Medicines Agency Accept Regulatory Submissions for Review of Talazoparib for Metastatic Breast Cancer Pat... Business Wire • Thu Jun 07, 2018 8:00 AM (2 weeks ago)
Pfizer to Expand Venture Investing with $600 Million Commitment to Pfizer Ventures Business Wire • Wed Jun 06, 2018 8:00 AM (2 weeks ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Jun 05, 2018 4:45 PM (2 weeks ago)
Dacomitinib Shows More than Seven-Month Improvement in Overall Survival Compared to an Established Therapy in Advanced NSCLC ... Business Wire • Mon Jun 04, 2018 5:37 PM (2 weeks ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
There is no data to display
Pfizer, Inc. Description
| Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments—Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare. |
